Spine Firms Laud CMS’ Decision To Cover Percutaneous Lumbar Decompression In Trials
This article was originally published in The Gray Sheet
Executive Summary
Spinal device makers, who objected to CMS’ proposal for outright noncoverage of percutaneous image-guided lumbar decompression, are pleased with the agency’s final decision to cover PILD when provided in a clinical study through coverage with evidence development.
You may also be interested in...
Medicare Slightly Expands Coverage For Spine Procedure, But Policy Remains Trial-Limited
Vertos Medical asked the US Medicare agency to reconsider its 2014 decision that limits coverage of percutaneous image-guided lumbar decompression for lumbar spine stenosis to certain clinical trials. The agency ruled Dec. 7 that it will stick with the trial-limited policy, but expanded it to include longitudinal studies.
Minimally Invasive Spine Technique Gets Second Look By CMS
The Medicare agency is reconsidering coverage of percutaneous image-guided lumbar decompression for lumbar spine stenosis in response to a request by device manufacturer Vertos. The firm's goal is to lift current clinical trial conditions for coverage of the procedure.
Research Briefs: VertiFlex Spine Trial; ReShape, EnteroMedics Data
VertiFlex launches a trial of its percutaneous image-guided lumbar decompression under CMS’ coverage with evidence development. Obesity device data from ReShape and EnteroMedics.